Are you Dr. Konrad?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 33 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Building 98a3 Rm 3109
Eli Lilly Corporate Center
Indianapolis, IN 46285Phone+1 317-655-9290Fax+1 317-276-5281- Is this information wrong?
Summary
- Dr. Robert Konrad, MD is a board certified pathologist in Indianapolis, Indiana. He is currently licensed to practice medicine in Indiana, Pennsylvania, and Alabama.
Education & Training
University of Pennsylvania Health SystemResidency, Pathology-Anatomic and Clinical, 1991 - 1996
Perelman School of Medicine at the University of PennsylvaniaClass of 1991
Certifications & Licensure
IN State Medical License 2001 - 2025
PA State Medical License 1994 - 2004
AL State Medical License Active through 2002- American Board of Pathology Clinical Pathology
Publications & Presentations
PubMed
- 8 citationsEffect of Costimulatory Blockade With Abatacept After Ustekinumab Withdrawal in Patients With Moderate to Severe Plaque Psoriasis: The PAUSE Randomized Clinical Trial., , , , , , , , , , , , , , , , , , > ;JAMA Dermatology. 2021 Oct 13
- 15 citationsAngiopoietin-like protein 4 (ANGPTL4) is an inhibitor of endothelial lipase (EL) while the ANGPTL4/8 complex has reduced EL-inhibitory activity.Yan Q. Chen, Thomas G. Pottanat, Robert W. Siegel, Mariam Ehsani, Yue-Wei Qian, Robert J. Konrad> ;Heliyon. 2021 Aug 30
- Novel methodology comparing two assay formats for the assessment of immunogenicity from clinical trial samplesDaniel A. Peterson, Thomas G. Pottanat, Heather Denning, Nicoletta Bivi, John H. Sloan, Huy T Nguyen, Matthew M. Hufford, Robert J. Konrad, Michael E Hodsdon> ;Bioanalysis. 2021 Jul 22
- Join now to see all
